jnj-67856633
Showing 1 - 2 of 2
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Non-Hodgkin
- JNJ-67856633
- Ibrutinib
-
Copenhagen, Denmark
- +9 more
Jan 27, 2023
Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Chronic Lymphocytic Leukemia
- JNJ-64264681
- JNJ-67856633
-
Stony Brook, New York
- +27 more
Aug 11, 2022